Further, they also found that more than 90% of CK19+ HCC cells in a tissue microarray cohort expressed at least one other stemness-related marker, while EpCAM, c-kit, and CD133 were more frequently expressed alone, implying that CK19 may be more “specifically” related to stemness than other markers. This evidence concerns the gene EPCAM and hepatocellular carcinoma.